Microbiology Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119 - 129, 08035, Barcelona, Spain.
Infectious Disease Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.
BMC Infect Dis. 2021 Oct 12;21(1):1056. doi: 10.1186/s12879-021-06763-8.
The importance of Mycobacterium tuberculosis strains with disputed rpoB mutations remains to be defined. This study aimed to assess the frequency and types of rpoB mutations in M. tuberculosis isolates from Cubal, Angola, a country with a high incidence of tuberculosis.
All isolates included (n = 308) were analyzed using phenotypic drug susceptibility testing and GenoType MTBDRplus assay. DNA sequencing of the rpoB gene and determination of rifampicin MIC by macrodilution method were additionally performed on isolates yielding discordant results (n = 12) and those in which the mutation detected was not characterized (n = 8).
In total, 85.1% (74/87) of rifampicin-resistant strains had undisputed rpoB mutations -S450L (49), D435V (15), H445D (3), H445Y (2), Q432ins (1), L449M plus S450F (1), S450F (1), S450W (1) and S450Y (1)-; 10.3% (9/87) had disputed rpoB mutations-L430P plus S493L (1), N437del (1), H445L (3), D435Y (2), L452P (2)-, 2.3% (2.3%) showed no rpoB mutations and 2.3% (2/87) showed heteroresistance-D435Y plus L452P and L430P plus S493L-.
Disputed rpoB mutations were common, occurring in 10.3% of rifampicin resistant isolates. Current phenotyping techniques may be unable to detect this resistance pattern. To increase their sensitivity, a lower concentration of RIF could be used in these tests or alternatively, rpoB mutations could be screened and characterized in all M. tuberculosis strains.
具有争议性 rpoB 突变的结核分枝杆菌菌株的重要性仍有待确定。本研究旨在评估安哥拉库巴尔(一个结核病发病率高的国家)分离的结核分枝杆菌菌株中 rpoB 突变的频率和类型。
对所有纳入的分离株(n=308)进行表型药物敏感性试验和 GenoType MTBDRplus 检测。对产生不一致结果的分离株(n=12)和未鉴定突变的分离株(n=8),进行 rpoB 基因的 DNA 测序和利福平 MIC 的微量稀释法测定。
共有 85.1%(74/87)的耐利福平菌株具有无争议的 rpoB 突变-S450L(49)、D435V(15)、H445D(3)、H445Y(2)、Q432ins(1)、L449M 加 S450F(1)、S450F(1)、S450W(1)和 S450Y(1);10.3%(9/87)为有争议的 rpoB 突变-L430P 加 S493L(1)、N437del(1)、H445L(3)、D435Y(2)、L452P(2);2.3%(2.3%)无 rpoB 突变;2.3%(2/87)为异质性耐药-D435Y 加 L452P 和 L430P 加 S493L。
有争议的 rpoB 突变很常见,占耐利福平分离株的 10.3%。目前的表型检测技术可能无法检测到这种耐药模式。为了提高其敏感性,可以在这些检测中使用较低浓度的 RIF,或者可以筛选和鉴定所有结核分枝杆菌菌株的 rpoB 突变。